Page last updated: 2024-11-11

streptimidone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

streptimidone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5351572
CHEMBL ID1981837
CHEBI ID189322
MeSH IDM0046669

Synonyms (15)

Synonym
9-methyl-streptimidone
streptimidione
(+)-4-((6e)(5s,2r)-2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dienyl)piperidine-2,6-dione
4-[(2r,5s,6e)-2-hydroxy-5,7-dimethyl-4-oxo-nona-6,8-dienyl]piperidine-2,6-dione
nsc-66645
streptimidone
NSC66645 ,
glutarimide,7-dimethyl-4-oxo-6,8-nonadienyl)-
738-72-7
CHEBI:189322
4-[(2r,5s,6e)-2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dienyl]piperidine-2,6-dione
2,6-piperidinedione,4-[(2r,5s,6e)-2-hydroxy- 5,7-dimethyl-4-oxo-6,8-nonadienyl]-
CHEMBL1981837
4-((2r,5s,e)-2-hydroxy-5,7-dimethyl-4-oxonona-6,8-dien-1-yl)piperidine-2,6-dione
DTXSID601317666
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tetrahydropyridine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.85 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]